Condition: Carcinoma Adrenal · Carcinoma, Adrenocortical Recurrent · Sponsor: Latin American Cooperative Oncology Group
This is a retrospective observational cohort study. The clinical, pathological and treatment data of participants identified with adrenocortical carcinoma from the year 2000 onwards will be evaluated. Participants recruited for this study will be identified at the participating sites.
This description comes directly from the study's public registry record.
Giana Blume Corssac · +55 51 3384 5334 · giana.corssac@lacogcancerresearch.org
Laura Voelcker · +55 51 3384 5334 · laura.voelcker@lacogcancerresearch.org
Always discuss trial participation with your own doctor first.
| Pronutrir - Suporte Nutricional e Quimioterapia | Fortaleza, Ceará, Brazil | Recruiting |
| Hospital do Câncer do Maranhão Dr. Tarquínio Lopes Filho | São Luís, Maranhão, Brazil | Recruiting |
| Hospital Erasto Gaertner | Curitiba, Paraná, Brazil | Recruiting |
| Hospital Santa Joana Recife (Instituto Américas PE) | Recife, Pernambuco, Brazil | Recruiting |
| UOPECCAN - Hospital do Câncer de Cascavel | Cascavel, Santa Catarina, Brazil | Recruiting |
| FUNFARME - Hospital de Base de São José do Rio Preto | São José do Rio Preto, São Paulo, Brazil | Recruiting |
| INCA - Instituto Nacional de Câncer | Rio de Janeiro, Brazil | Recruiting |
| BP - A Beneficência Portuguesa de São Paulo | São Paulo, Brazil | Recruiting |
| HAOC - Hospital Alemão Oswaldo Cruz | São Paulo, Brazil | Recruiting |
| A.C. Camargo Cancer Center | São Paulo, Brazil | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06279442